Ensysce Biosciences Stock Price Prediction
| ENSC Stock | USD 0.58 0.05 7.94% |
Oversold Vs Overbought
45
Oversold | Overbought |
Ensysce Biosciences stock price prediction is an act of determining the future value of Ensysce Biosciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Ensysce Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ensysce Biosciences and does not consider all of the tangible or intangible factors available from Ensysce Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Ensysce Biosciences, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Ensysce Biosciences' stock price prediction:EPS Estimate Next Quarter (0.83) | EPS Estimate Current Year (3.02) | EPS Estimate Next Year (2.33) | Wall Street Target Price 11.33 | EPS Estimate Current Quarter (0.87) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Ensysce Biosciences based on different types of headlines from major news networks to social media. The Ensysce stock price prediction module provides an analysis of price elasticity to changes in media outlook on Ensysce Biosciences over a specific investment horizon. Using Ensysce Biosciences hype-based prediction, you can estimate the value of Ensysce Biosciences from the perspective of Ensysce Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Ensysce Biosciences. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Ensysce Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Ensysce because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ensysce Biosciences after-hype prediction price | USD 0.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ensysce |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ensysce Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Ensysce Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ensysce Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ensysce Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ensysce Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Ensysce Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ensysce Biosciences' historical news coverage. Ensysce Biosciences' after-hype downside and upside margins for the prediction period are 0.03 and 7.36, respectively. We have considered Ensysce Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ensysce Biosciences is very risky at this time. Analysis and calculation of next after-hype price of Ensysce Biosciences is based on 3 months time horizon.
Ensysce Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ensysce Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ensysce Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ensysce Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.83 | 6.79 | 0.01 | 0.06 | 9 Events / Month | 3 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.58 | 0.57 | 1.72 |
|
Ensysce Biosciences Hype Timeline
Ensysce Biosciences is currently traded for 0.58. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.06. Ensysce is projected to decline in value after the next headline, with the price expected to drop to 0.57. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.72%, whereas the daily expected return is currently at -0.83%. The volatility of related hype on Ensysce Biosciences is about 10059.26%, with the expected price after the next announcement by competition of 0.52. The company has price-to-book (P/B) ratio of 1.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ensysce Biosciences recorded a loss per share of 4.69. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 31st of March 2023. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Ensysce Biosciences Basic Forecasting Models to cross-verify your projections.Ensysce Biosciences Related Hype Analysis
Having access to credible news sources related to Ensysce Biosciences' direct competition is more important than ever and may enhance your ability to predict Ensysce Biosciences' future price movements. Getting to know how Ensysce Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ensysce Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PMVP | Pmv PharmaceuticalsInc | (0.01) | 4 per month | 0.00 | (0.08) | 6.67 | (8.38) | 21.67 | |
| PEPG | PepGen | 0.04 | 10 per month | 5.46 | 0.13 | 17.58 | (9.88) | 67.46 | |
| MOLN | Molecular Partners AG | (0.28) | 4 per month | 0.00 | (0.10) | 4.90 | (6.52) | 23.10 | |
| ADAG | Adagene | (0.02) | 5 per month | 0.00 | (0.05) | 10.16 | (13.14) | 32.26 |
Ensysce Biosciences Additional Predictive Modules
Most predictive techniques to examine Ensysce price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ensysce using various technical indicators. When you analyze Ensysce charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ensysce Biosciences Predictive Indicators
The successful prediction of Ensysce Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ensysce Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ensysce Biosciences based on analysis of Ensysce Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ensysce Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ensysce Biosciences's related companies. | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.56 | 0.005391 | 0.005121 | Price To Sales Ratio | 0.64 | 1.08 | 1.02 |
Story Coverage note for Ensysce Biosciences
The number of cover stories for Ensysce Biosciences depends on current market conditions and Ensysce Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ensysce Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ensysce Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Ensysce Biosciences Short Properties
Ensysce Biosciences' future price predictability will typically decrease when Ensysce Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ensysce Biosciences often depends not only on the future outlook of the potential Ensysce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ensysce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.3 M | |
| Cash And Short Term Investments | 1.1 M |
Check out Ensysce Biosciences Basic Forecasting Models to cross-verify your projections. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Ensysce Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.69) | Revenue Per Share 0.985 | Quarterly Revenue Growth (0.64) | Return On Assets (1.56) | Return On Equity (13.20) |
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.